当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第17期
编号:2390349
糠酸莫米松鼻喷雾剂联合孟鲁司特钠对鼾症患儿的影响
http://www.100md.com 2025年8月14日 中国医学创新 2025年第17期
    

    Effectof MometasoneFuroateNasal SprayCombined with Montelukast Sodiumon Childrenwith Snoring/DUXin.//MedicalInnovationofChina,2025,22(17):124-128

    [Abstract]Objective:To explorethe efectof MometasoneFuroateNasal Spraycombined with Montelukast Sodium on children with snoring.Method:A totalof10O childrenwith snoring admited to from January 2022 to January 2O24 were selectedand grouped by the ball touch method.Odd numbers were classified as the control group (n=5O),and even numbers were clasified as the observation group ( n =50). The control group was treated with Montelukast Sodium, while the observation group was treated with Mometasone Furoate Nasal Spray combined with Montelukast Sodium.The clinical efficacy,inflammation indicators [interleukin-6 (IL-6), tumor necrosis factor- α (TNF -α )],ventilation function [arterial partial pressure of oxygen (PaO2),minimum blood oxygen saturation (LSpO2),oxygendecrement index(ODI)],and sleep quality [pediatric sleep questionnaire (PSQ)] before treatment and one month after treatment between the two groups were compared. Result: The total effectiverate of treatment in the observation group was higher than that inthe control group ......

您现在查看是摘要页,全文长 13060 字符